Log in
Enquire now
Protiva Biotherapeutics

Protiva Biotherapeutics

A biotechnology company developing nucleic acid based pharmaceutical products for the treatment of cancer, influenza, Ebola, inflammatory diseases and chronic viral infections

OverviewStructured DataIssuesContributors

Contents

protivabio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biology
Biology
Technology
Technology
Biotechnology
Biotechnology
Location
Seattle
Seattle
AngelList URL
angel.co/protiva-bi...herapeutics
Pitchbook URL
pitchbook.com/profiles.../52303-69
Total Funding Amount (USD)
8,260,000
Latest Funding Round Date
July 5, 2007
Acquisition Transaction
‌
Acquisition of Protiva Biotherapeutics by Tekmira Pharmaceuticals
Latest Funding Type
Series D
Series D
Wellfound ID
protiva-biotherapeutics

Other attributes

Company Operating Status
Closed
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Protiva Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.